| Date | Time | Source | Headline | Symbol | Company |
| 11/24/2010 | 2:24PM | Dow Jones News | Gilead Plant Problems Detailed In FDA Inspection Report | NASDAQ:GILD | Gilead Sciences Inc |
| 11/24/2010 | 9:31AM | PR Newswire (US) | Critical Alerts for Coca-Cola, Gilead Sciences, Ingersoll-Rand, Symantec, and Harbin Electric Released by Seven Summits Research | NASDAQ:GILD | Gilead Sciences Inc |
| 11/23/2010 | 4:30PM | Business Wire | Gilead Sciences to Present at the 22nd Annual Piper Jaffray Healthcare Conference on Tuesday, November 30 | NASDAQ:GILD | Gilead Sciences Inc |
| 11/23/2010 | 8:30AM | Business Wire | Gilead Sciences Submits New Drug Application to U.S. FDA for Once-Daily Single-Tablet Regimen of Truvada® and TMC278 for HIV | NASDAQ:GILD | Gilead Sciences Inc |
| 11/12/2010 | 12:11PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/12/2010 | 12:07PM | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/12/2010 | 12:05PM | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/09/2010 | 9:21PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/09/2010 | 8:46AM | Marketwired | Obama Extends an Olive Branch to the Biotech Industry | NASDAQ:GILD | Gilead Sciences Inc |
| 11/09/2010 | 6:08AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/08/2010 | 7:05PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/08/2010 | 5:03PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/05/2010 | 8:30AM | Business Wire | Dr. Paul Berg to Retire from Gilead Sciences’ Board of Directors | NASDAQ:GILD | Gilead Sciences Inc |
| 11/04/2010 | 4:30PM | Business Wire | Gilead Sciences to Present at the 2010 Credit Suisse Healthcare Conference on Thursday, November 11 | NASDAQ:GILD | Gilead Sciences Inc |
| 11/01/2010 | 6:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 10/30/2010 | 9:01AM | Business Wire | Viread® for Hepatitis B Maintains Antiviral Suppression with No Development of Resistance Through Four Years of Treatment | NASDAQ:GILD | Gilead Sciences Inc |
| 10/30/2010 | 9:00AM | Business Wire | Gilead’s Investigational Hepatitis C Compounds GS 9190 & GS 9256 in Combination with Standard of Care Therapies Achieve Sub... | NASDAQ:GILD | Gilead Sciences Inc |
| 10/29/2010 | 1:45PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 10/27/2010 | 9:43AM | Marketwired | Wall Street News Alert: Market Watch: Unity Management Group -- October 27, 2010 | NASDAQ:GILD | Gilead Sciences Inc |
| 10/26/2010 | 8:14PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 10/22/2010 | 6:00PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 10/21/2010 | 11:50AM | Business Wire | Gilead’s Cayston® Superior to Tobramycin Inhalation Solution in Six-Month Head-to-Head Cystic Fibrosis Study | NASDAQ:GILD | Gilead Sciences Inc |
| 10/21/2010 | 9:31AM | PR Newswire (US) | Critical Alerts for Las Vegas Sands, Applied Materials, Gilead Sciences, Banco Bradesco, and Alliance Data Systems Released by S | NASDAQ:GILD | Gilead Sciences Inc |
| 10/19/2010 | 6:29PM | Dow Jones News | UPDATE: Gilead 3Q Profit Rises 4.7% On Strong HIV Sales | NASDAQ:GILD | Gilead Sciences Inc |
| 10/19/2010 | 5:35PM | Dow Jones News | CORRECT: Gilead Sciences 3Q Profit Up 4.7%; Results Beat Views | NASDAQ:GILD | Gilead Sciences Inc |
| 10/19/2010 | 5:16PM | Dow Jones News | Gilead Backs 2010 Product Sales $7.3 Billion-$7.4 Billion | NASDAQ:GILD | Gilead Sciences Inc |
| 10/19/2010 | 4:52PM | Dow Jones News | Gilead Sciences 3Q Profit Up 7.4%; Results Beat Views | NASDAQ:GILD | Gilead Sciences Inc |
| 10/19/2010 | 4:20PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 10/19/2010 | 4:05PM | Business Wire | Gilead Sciences Announces Third Quarter 2010 Financial Results | NASDAQ:GILD | Gilead Sciences Inc |
| 10/18/2010 | 3:39PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |